Your browser doesn't support javascript.
loading
The transmembrane domain and luminal C-terminal region independently support invariant chain trimerization and assembly with MHCII into nonamers.
Cloutier, Maryse; Fortin, Jean-Simon; Thibodeau, Jacques.
Afiliação
  • Cloutier M; Laboratoire d'Immunologie Moléculaire, Département de Microbiologie, Infectiologie et Immunologie, Faculté de Médecine, Université de Montréal, Succ Centre-Ville, CP 6128, Montréal, QC, H3C 3J7, Canada.
  • Fortin JS; Laboratoire d'Immunologie Moléculaire, Département de Microbiologie, Infectiologie et Immunologie, Faculté de Médecine, Université de Montréal, Succ Centre-Ville, CP 6128, Montréal, QC, H3C 3J7, Canada.
  • Thibodeau J; Laboratoire d'Immunologie Moléculaire, Département de Microbiologie, Infectiologie et Immunologie, Faculté de Médecine, Université de Montréal, Succ Centre-Ville, CP 6128, Montréal, QC, H3C 3J7, Canada. Jacques.Thibodeau@umontreal.ca.
BMC Immunol ; 22(1): 56, 2021 08 12.
Article em En | MEDLINE | ID: mdl-34384367
ABSTRACT

BACKGROUND:

Invariant chain (CD74, Ii) is a multifunctional protein expressed in antigen presenting cells. It assists the ER exit of various cargos and serves as a receptor for the macrophage migration inhibitory factor. The newly translated Ii chains trimerize, a structural feature that is not readily understood in the context of its MHCII chaperoning function. Two segments of Ii, the luminal C-terminal region (TRIM) and the transmembrane domain (TM), have been shown to participate in the trimerization process but their relative importance and impact on the assembly with MHCII molecules remains debated. Here, we addressed the requirement of these domains in the trimerization of human Ii as well as in the oligomerization with MHCII molecules. We used site-directed mutagenesis to generate series of Ii and DR mutants. These were transiently transfected in HEK293T cells to test their cell surface expression and analyse their interactions by co-immunoprecipitations.

RESULTS:

Our results showed that the TRIM domain is not essential for Ii trimerization nor for intracellular trafficking with MHCII molecules. We also gathered evidence that in the absence of TM, TRIM allows the formation of multi-subunit complexes with HLA-DR. Similarly, in the absence of TRIM, Ii can assemble into high-order structures with MHCII molecules.

CONCLUSIONS:

Altogether, our data show that trimerization of Ii through either TM or TRIM sustains nonameric complex formation with MHCII molecules.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antígenos de Diferenciação de Linfócitos B / Antígenos HLA-DR / Antígenos de Histocompatibilidade Classe II / Membrana Celular Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antígenos de Diferenciação de Linfócitos B / Antígenos HLA-DR / Antígenos de Histocompatibilidade Classe II / Membrana Celular Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article